Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000992943 | SCV001145560 | uncertain significance | not provided | 2018-09-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002346197 | SCV002653869 | uncertain significance | Inborn genetic diseases | 2019-11-06 | criteria provided, single submitter | clinical testing | The p.D182E variant (also known as c.546C>A), located in coding exon 4 of the SETX gene, results from a C to A substitution at nucleotide position 546. The aspartic acid at codon 182 is replaced by glutamic acid, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV002549817 | SCV003304495 | benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2022-02-21 | criteria provided, single submitter | clinical testing |